Contribution of MxB oligomerization to HIV-1 capsid binding and restriction

Journal of Virology

Volumn 89, Issue 6, 2015, Pages 3285-3294

  Buffone, Cindy ^a   Schulte, Bianca ^a   Opp, Silvana ^a   Diaz Griffero, Felipe ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN; GAG PROTEIN; MX2 PROTEIN, HUMAN; MYXOVIRUS RESISTANCE PROTEIN; PROTEIN BINDING;

ARTICLE; BASIC LEUCINE ZIPPER MOTIF; BINDING SITE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MUTAGENICITY; MUTATIONAL ANALYSIS; MYXOVIRUS B; NONHUMAN; OLIGOMERIZATION; ORGANISMAL INTERACTION; ORTHOMYXOVIRUS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; VIRUS ASSEMBLY; VIRUS ATTACHMENT; VIRUS CAPSID; VIRUS MUTATION; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; PROTEIN MULTIMERIZATION; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE; ORTHOMYXOVIRIDAE;

CAPSID; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; MODELS, MOLECULAR; MYXOVIRUS RESISTANCE PROTEINS; PROTEIN BINDING; PROTEIN MULTIMERIZATION;

EID: 84923172327     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03730-14     Document Type: Article

References (42)

1. Mitchell PS, Emerman M, Malik HS. 2013. An evolutionary perspective on the broad antiviral specificity of MxA. Curr Opin Microbiol 16:493-499. http://dx.doi.org/10.1016/j.mib.2013.04.005.
2. Haller O, Kochs G. 2011. Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity. J Interferon Cytokine Res 31:79-87. http://dx.doi.org/10.1089/jir.2010.0076.
3. Melén K, Keskinen P, Ronni T, Sareneva T, Lounatmaa K, Julkunen I. 1996. Human MxB protein, an interferon-alpha-inducible GTPase, contains a nuclear targeting signal and is localized in the heterochromatin region beneath the nuclear envelope. J Biol Chem 271:23478-23486. http://dx.doi.org/10.1074/jbc.271.38.23478.
4. Aebi M, Fäh J, Hurt N, Samuel CE, Thomis D, Bazzigher L, Pavlovic J, Haller O, Staeheli P. 1989. cDNA structures and regulation of two interferon-induced human Mx proteins. Mol Cell Biol 9:5062-5072.
5. Haller O. 2013. Dynamins are forever: MxB inhibits HIV-1. Cell Host Microbe 14:371-373. http://dx.doi.org/10.1016/j.chom.2013.10.002.
6. Haller O, Gao S, von der Malsburg A, Daumke O, Kochs G. 2010. Dynamin-like MxA GTPase: structural insights into oligomerization and implications for antiviral activity. J Biol Chem 285:28419-28424. http://dx.doi.org/10.1074/jbc.R110.145839.
7. Faelber K, Gao S, Held M, Posor Y, Haucke V, Noé F, Daumke O. 2013. Oligomerization of dynamin superfamily proteins in health and disease. Prog Mol Biol Transl Sci 117:411-443. http://dx.doi.org/10.1016/B978-0-12-386931-9.00015-5.
8. Liu Z, Pan Q, Ding S, Qian J, Xu F, Zhou J, Cen S, Guo F, Liang C. 2013. The interferon-inducible MxB protein inhibits HIV-1 Infection. Cell Host Microbe 14:398-410. http://dx.doi.org/10.1016/j.chom.2013 .08.015.
9. Morlot S, Roux A. 2013. Mechanics of dynamin-mediated membrane fission. Annu Rev Biophys 42:629-649. http://dx.doi.org/10.1146/annurev-biophys-050511-102247.
10. McNew JA, Sondermann H, Lee T, Stern M, Brandizzi F. 2013. GTPdependent membrane fusion. Annu Rev Cell Dev Biol 29:529-550. http://dx.doi.org/10.1146/annurev-cellbio-101512-122328.
11. Gao S, von der Malsburg A, Paeschke S, Behlke J, Haller O, Kochs G, Daumke O. 2010. Structural basis of oligomerization in the stalk region of dynamin-like MxA. Nature 465:502-506. http://dx.doi.org/10.1038/nature08972.
12. Pavlovic J, Zürcher T, Haller O, Staeheli P. 1990. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J Virol 64:3370-3375.
13. Xiao H, Killip MJ, Staeheli P, Randall RE, Jackson D. 2013. The human interferon-induced MxA protein inhibits early stages of influenza A virus infection by retaining the incoming viral genome in the cytoplasm. J Virol 87:13053-13058. http://dx.doi.org/10.1128/JVI.02220-13.
14. Matzinger SR, Carroll TD, Dutra JC, Ma Z-M, Miller CJ. 2013. Myxovirus resistance gene A (MxA) expression suppresses influenza A virus replication in alpha interferon-treated primate cells. J Virol 87:1150-1158. http://dx.doi.org/10.1128/JVI.02271-12.
15. Frese M, Kochs G, Meier-Dieter U, Siebler J, Haller O. 1995. Human MxA protein inhibits tick-borne Thogoto virus but not Dhori virus. J Virol 69:3904-3909.
16. Netherton CL, Simpson J, Haller O, Wileman TE, Takamatsu H-H, Monaghan P, Taylor G. 2009. Inhibition of a large double-stranded DNA virus by MxA protein. J Virol 83:2310-2320. http://dx.doi.org/10.1128/JVI.00781-08.
17. Li N, Zhang L, Chen L, Feng W, Xu Y, Chen F, Liu X, Chen Z, Liu W. 2012. MxA inhibits hepatitis B virus replication by interaction with hepatitis B core antigen. Hepatology 56:803-811. http://dx.doi.org/10.1002/hep.25608.
18. Kochs G, Janzen C, Hohenberg H, Haller O. 2002. Antivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexes. Proc Natl Acad SciUSA99:3153-3158. http://dx.doi.org/10.1073/pnas.052430399.
19. Reichelt M, Stertz S, Krijnse-Locker J, Haller O, Kochs G. 2004. Missorting of LaCrosse virus nucleocapsid protein by the interferon-induced MxA GTPase involves smooth ER membranes. Traffic 5:772-784. http://dx.doi.org/10.1111/j.1600-0854.2004.00219.x.
20. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM. 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481-485. http://dx.doi.org/10 .1038/nature09907.
21. Goujon C, Moncorgé O, Bauby H, Doyle T, Ward CC, Schaller T, Hué S, Barclay WS, Schulz R, Malim MH. 2013. Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature 502:559-562. http://dx.doi.org/10.1038/nature12542.
22. Kane M, Yadav SS, Bitzegeio J, Kutluay SB, Zang T, Wilson SJ, Schoggins JW, Rice CM, Yamashita M, Hatziioannou T, Bieniasz PD. 2013. MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature 502: 563-566. http://dx.doi.org/10.1038/nature12653.
23. Fricke T, White TE, Schulte B, de Souza Aranha Vieira DA, Dharan A, Campbell EM, Brandariz-Nuñez A, Diaz-Griffero F. 2014. MxB binds to the HIV-1 core and prevents the uncoating process of HIV-1. Retrovirology 11:68. http://dx.doi.org/10.1186/PREACCEPT-6453674081373986.
24. Goujon C, Moncorgé O, Bauby H, Doyle T, Barclay WS, Malim MH. 2014. Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factor. J Virol 88:9017-9026. http://dx.doi.org/10.1128/JVI.01269-14.
25. Busnadiego I, Kane M, Rihn SJ, Preugschas HF, Hughes J, Blanco-Melo D, Strouvelle VP, Zang TM, Willett BJ, Boutell C, Bieniasz PD, Wilson SJ. 2014. Host and viral determinants of Mx2 antiretroviral activity. J Virol 88:7738-7752. http://dx.doi.org/10.1128/JVI.00214-14.
26. Yang Y, Brandariz-Nuñez A, Fricke T, Ivanov DN, Sarnak Z, Diaz-Griffero F. 2014. Binding of the rhesus TRIM5α PRYSPRY domain to capsid is necessary but not sufficient for HIV-1 restriction. Virology 448: 217-228. http://dx.doi.org/10.1016/j.virol.2013.10.012.
27. Ganser BK, Li S, Klishko VY, Finch JT, Sundquist WI. 1999. Assembly and analysis of conical models for the HIV-1 core. Science 283:80-83. http://dx.doi.org/10.1126/science.283.5398.80.
28. Diaz-Griffero F, Perron M, McGee-Estrada K, Hanna R, Maillard PV, Trono D, Sodroski J. 2008. A human TRIM5α B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus. Virology 378:233-242. http://dx.doi.org/10.1016/j .virol.2008.05.008.
29. Melén K, Ronni T, Broni B, Krug RM, von Bonsdorff CH, Julkunen I. 1992. Interferon-induced Mx proteins form oligomers and contain a putative leucine zipper. J Biol Chem 267:25898-25907.
30. Fricke T, Brandariz-Nunez A, Wang X, Smith AB, Diaz-Griffero F. 2013. Human cytosolic extracts stabilize the HIV-1 core. J Virol 87:10587-10597. http://dx.doi.org/10.1128/JVI.01705-13.
31. Diaz-Griffero F, Kar A, Perron M, Xiang S-H, Javanbakht H, Li X, Sodroski J. 2007. Modulation of retroviral restriction and proteasome inhibitor-resistant turnover by changes in the TRIM5alpha B-box 2 domain. J Virol 81:10362-10378. http://dx.doi.org/10.1128/JVI.00703-07.
32. Kar AK, Diaz-Griffero F, Li Y, Li X, Sodroski J. 2008. Biochemical and biophysical characterization of a chimeric TRIM21-TRIM5 protein. J Virol 82:11669-11681. http://dx.doi.org/10.1128/JVI.01559-08.
33. Langelier CR, Sandrin V, Eckert DM, Christensen DE, Chandrasekaran V, Alam SL, Aiken C, Olsen JC, Kar AK, Sodroski JG, Sundquist WI. 2008. Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication. J Virol 82:11682-11694. http://dx.doi.org/10.1128/JVI.01562-08.
34. Javanbakht H, Yuan W, Yeung DF, Song B, Diaz-Griffero F, Li Y, Li X, Stremlau M, Sodroski J. 2006. Characterization of TRIM5alpha trimeriza-tion and its contribution to human immunodeficiency virus capsid binding. Virology 353:234-246. http://dx.doi.org/10.1016/j.virol.2006.05.017.
35. Biris N, Tomashevski A, Bhattacharya A, Diaz-Griffero F, Ivanov DN. 2013. Rhesus monkey TRIM5α SPRY domain recognizes multiple epitopes that span several capsid monomers on the surface of the HIV-1 mature viral core. J Mol Biol 425:5032-5044. http://dx.doi.org/10.1016/j .jmb.2013.07.025.
36. Diaz-Griffero F. 2011. Caging the beast: TRIM5α binding to the HIV-1 core. Viruses 3:423-428. http://dx.doi.org/10.3390/v3050423.
37. Gao S, von der Malsburg A, Dick A, Faelber K, Schröder GF, Haller O, Kochs G, Daumke O. 2011. Structure of myxovirus resistance protein A reveals intraand intermolecular domain interactions required for the antiviral function. Immunity 35:514-525. http://dx.doi.org/10.1016/j.immuni.2011.07.012.
38. Diaz-Griffero F, Qin XR, Hayashi F, Kigawa T, Finzi A, Sarnak Z, Lienlaf M, Yokoyama S, Sodroski J. 2009. A B-box 2 surface patch important for TRIM5 self-association, capsid binding avidity, and retrovirus restriction. J Virol 83: 10737-10751. http://dx.doi.org/10.1128/JVI.01307-09.
39. Ganser-Pornillos BK, Chandrasekaran V, Pornillos O, Sodroski JG, Sundquist WI, Yeager M. 2011. Hexagonal assembly of a restricting TRIM5alpha protein. Proc Natl Acad SciUSA108:534-539. http://dx.doi .org/10.1073/pnas.1013426108.
40. Stremlau M, Perron M, Lee M, Li Y, Song B, Javanbakht H, Diaz-Griffero F, Anderson DJ, Sundquist WI, Sodroski J. 2006. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc Natl Acad Sci U S A 103:5514-5519. http://dx.doi.org/10.1073/pnas.0509996103.
41. Diaz-Griffero F, Kar A, Lee M, Stremlau M, Poeschla E, Sodroski J. 2007. Comparative requirements for the restriction of retrovirus infection by TRIM5alpha and TRIMCyp. Virology 369:400-410. http://dx.doi.org/10.1016/j.virol.2007.08.032.
42. Fribourgh JL, Nguyen HC, Matreyek KA, Alvarez FJD, Summers BJ, Dewdney TG, Aiken C, Zhang P, Engelman A, Xiong Y. 2014. Structural insight into HIV-1 restriction by MxB. Cell Host Microbe 16:627-638. http://dx.doi.org/10.1016/j.chom.2014.09.021.